Related Experiment Videos
Malignancies of undetermined primary origin.
1Section Hematology/Oncology Pritzker School of Medicine, Lutheran General Hospital, Park Ridge, Illinois.
Disease-A-Month : DM
|April 1, 1992
Summary
Unknown primary malignancy (UPM) diagnosis requires thorough workup and pathologist collaboration. Advanced techniques like immunocytochemistry aid in classifying these diverse cancers, some of which are treatable.
Area of Science:
- Oncology
- Pathology
Background:
- Unknown primary malignancy (UPM) encompasses diverse metastatic cancers with occult or undifferentiated origins.
- UPM presents a diagnostic challenge, ranging from curable to fatal conditions.
Purpose of the Study:
- To outline the diagnostic approach for unknown primary malignancies.
- To highlight the role of advanced laboratory techniques in accurate cancer classification.
Main Methods:
- Initial workup includes history, physical exam, blood counts, urinalysis, chemistries, and CT scans.
- Further diagnosis relies on pathologist collaboration and laboratory tests like electron microscopy, histochemical stains, and immunocytochemistries.
- An initial panel of immunocytochemistries (vimentin, cytokeratin, CEA, common leukocyte antigen) is recommended.
Main Results:
- Immunocytochemistries significantly improve the accurate pathologic diagnosis of UPM.
- Chromosomal analysis aids in identifying lymphomas and soft-tissue sarcomas.
- Specific treatable UPMs include lymphoma, germ cell malignancies, and certain metastatic adenocarcinomas.
Conclusions:
- Accurate classification of UPM is crucial for determining prognosis and treatment.
- Future molecular-level diagnostics will further refine UPM classification.
- While some UPMs are treatable, many metastatic adenocarcinomas of unknown origin have a poor prognosis.